Adverse effects of systemic glucose absorption with peritoneal dialysis: How good is the evidence?

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 6, 2013, Pages 663-668

  Mehrotra, Rajnish ^a   De Boer, Ian H ^a   Himmelfarb, Jonathan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

dyslipidemia; end stage renal disease; glucose; hyperglycemia; peritoneal dialysis

Indexed keywords

GLUCOSE; ICODEXTRIN;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DEATH; DYSLIPIDEMIA; ERYTHROPOIESIS; FOLLOW UP; GLUCOSE ABSORPTION; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; WEIGHT GAIN;

ABSORPTION; BLOOD GLUCOSE; DIALYSIS SOLUTIONS; DYSLIPIDEMIAS; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RISK FACTORS; WEIGHT GAIN;

EID: 84887015891     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328365b3d1     Document Type: Review

References (40)

1. Mehrotra R, Kermah D, Fried L, et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007; 18:2781-2788.
2. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20:155-163.
3. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27:3568-3575.
4. Chang YK, Hsu CC, Hwang SJ, et al. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Medicine (Baltimore) 2012; 91:144-151.
5. Greneche S, Dandon A, Jacquelinet C, et al. Choosing between peritoneal dialysis and haemodialysis: a critical appraisal of the literature. Nephrologie Therapeutique 2005; 1:213-220.
6. Mehrotra R, Chiu YW, Kalantar-Zadeh K, et al. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171:110-118.
7. Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21:499-506.
8. United States Renal Data System Annual Data Report. Bethesda, MD: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health; 2012.
9. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53:475-491.
10. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4:1925-1931.
11. Rottembourg J, Issad B,Gallego JL, et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 19:397-403.
12. Lysaght MJ, Vonesh EF, Gotch F, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37:598-604.
13. Misra M, Vonesh E, Van Stone JC, et al. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int 2001; 59:754-763.
14. Jansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-1053.
15. Mujais S, Vonesh E. Profiling of peritoneal ultrafiltration. Kidney Int Suppl 2002; S17-S22.
16. Burkart J. Metabolic consequences of peritoneal dialysis. Semin Dial 2004; 17:498-504.
17. Paniagua R, Ventura MD, Avila-Diaz M, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int 2009; 29:422-432.
18. Baxter Healthcare. Press release: Baxter's low glucose PD solutions favorably impacted metabolic measures including glycemic control in trials of diabetics undergoing dialysis. 2012. http://www.baxter.com/press-room/press- releases/2012/05-25-12-impendia-eden.html. [Accessed 10 July 2013]
19. Davies SJ, Russell L, Bryan J, et al. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients. Clin Nephrol 1996; 45:194-198.
20. Wu HY, Hung KY, Huang JW, et al. Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol 2008; 28:765-771.
21. Wu HY, Hung KY, Huang TM, et al. Safety issues of long-term glucose load in patients on peritoneal dialysis: a 7-year cohort study. PLoS ONE 2012; 7:e30337.
22. Skubala A, Zywiec J, Zelobowska K, et al. Continuous glucose monitoring system in 72-h glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis. Med Sci Monit 2010; 16:CR75-CR83.
23. Marshall J, Jennings P, Scott A, et al. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64:1480-1486.
24. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007; 18:896-903.
25. Freedman BI, Shenoy RN, Planer JA, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 2010; 30:72-79.
26. Mehrotra R, Kalantar-Zadeh K, Adler S. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol 2011; 6:1520-1522.
27. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-853.
29. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
30. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559.
31. Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 2011; 6:1041-1048.
32. Shurraw S, Tonelli M. Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int 2006; 26:523-539.
33. Kronenberg F, Lingenhel A, Neyer U, et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003; S113-S116.
34. Bredie SJ, Bosch FH, Demacker PN, et al. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21:275-281.
35. Lin A, Qian J, Li X, et al. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol 2009; 4:1799-1804.
36. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377:2181-2192.
37. Jager KJ, Merkus MP, Huisman RM, et al. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001; 12:1272-1279.
38. Lievense H, Kalantar-Zadeh K, Lukowsky L, et al. Interrelationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain. Nephrol Dial Transplant 2012; 27:3631-3638.
39. Mehrotra R, Berman N, Alistwani A, Kopple JD. Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis 2002; 40:133-142.
40. Pellicano R, Strauss BJ, Polkinghorne KR, Kerr PG. Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol 2011; 6:1668-1675.